Findings from the ESTIMATE algorithm revealed significant negative correlations between GNAL expression and StromalScore, ImmuneScore, and EstimateScore, implying that glioma patients with low GNAL expression may not mount strong anti-tumor immune responses that can then induce immune escape. The gene discussed is GNAL; the disease is central nervous system cancer.